Search results
Potential Price Increase for Pfizer Inc.
Knox Daily· 6 days agoPfizer Inc.’s filing revealed that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
Chiefs TE Travis Kelce, Social Media Sensation Livvy Dunne Star in New Commercial: ‘Making...
MSN News· 1 day agoKansas City Chiefs All-Pro tight end Travis Kelce has been in the news for off-field reasons plenty...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 1 day agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Morningstar· 3 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer ...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA TODAY via Yahoo News· 3 hours agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were ...
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in...
Morningstar· 3 days agoTherapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, ...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Stars and Stripes· 20 hours agoThe U.S. health regulator on Friday advised COVID-19 vaccine manufacturers that new shots for the...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 1 day agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19...
My 3 Top Stocks to Buy in June
247wallst.com· 4 days ago24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE:...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...